ATP Assays Market by Product (Consumables (Kits, Reagent, Microplate), Instrument (Luminometer, Spectrophotometers)), Application (Contamination, Disease Testing, Drug Discovery), End User (Hospitals, Pharmaceuticals, Food Testing) - Global Forecast to 2027
Instant Answers with GPT - Ask Now!
Ask real questions. Get complete answers !
Generating Response ...[226 Pages Report] The global ATP assays market is projected to reach USD 412 million by 2027 from USD 276 million in 2022, at a CAGR of 8.4%. Growth in this market is majorly driven by the use of advanced technologies in microbial detection, rising demand for cell-based assays in research, increasing investments in cancer and stem cell research, and the high prevalence of chronic diseases (coupled with the increasing demand for early and effective disease diagnosis and treatment).
To know about the assumptions considered for the study, Request for Free Sample Report
COVID-19 Impact on ATP Assays Market
During the COVID-19 pandemic surge, various cleaning strategies were evaluated in hospitals to prevent healthcare-associated infections. For cleaning in acute care hospitals and long-term facilities, SARS COV-2 RT-PCR and ATP assays are used.
Manufacturing of vaccine production during pandemics has led to an increase in the adoption of cell culture media for COVID-19 research. Vaccine-related research activities in pharmaceutical & biotechnological companies, research centers, and academic research institutes are considered essential and have been largely unaffected in operations and output. Currently, a number of vaccines or antiviral drugs for COVID-19 have been approved or are under development and manufacturing. This has increased the demand for cell assay products like ATP assays used for the decontamination of surfaces and equipment in pharmaceutical companies and hospital settings.
The use of ATP assays is expected to grow considering the positive impact on overall research applications of cell-based assay products, increased demand for cell-based assays in drugs and vaccines development, the number of drug and biologics approvals, overall clinical trials, and growing biologics market with the increase in pharma R&D spending.
Atp Assays Market Dynamics
Driver: Increasing food safety concerns
To ensure best-quality products with minimum health risks, several governments and companies have promulgated regulations to stipulate tolerable levels of contaminants, residues, and additives in food products. It reduces the risk of foodborne illnesses, closures, and recalls and can also improve efficiency and reduce costs.
Food contamination is one of the major global concerns, which results in deaths, several health complications, and diseases.
Food production facilities rely on ATP tests to see if the food-contact surfaces are cleaned properly. It also checks that the surfaces are free from unsafe microbial loads and should adhere to the safety and quality of the products.
According to the Food Safety and Standards Authority of India, there is a consistent increase in food adulteration cases in India. Therefore, increasing food-safety concerns and the need to prevent adulteration and maintain the quality of food has increased the demand for ATP.
Restraint: High cost of instruments
The use of advanced cell viability assays is largely dependent on the availability of instruments, such as flow cytometers, high-throughput screening devices, luminometers, spectrophotometers, and high-content screening systems. As these systems are equipped with advanced features and functionalities, they are priced at a premium.
The cost of research in cell biology is high because of the need to maintain high-quality standards (use of high-grade, expensive products). Furthermore, it becomes difficult for small hospitals, diagnostic laboratories, and research & academic laboratories to acquire these instruments owing to budget constraints. In addition, the maintenance costs and several other indirect expenses result in an overall increase in the total cost of ownership of these instruments. This is a major factor limiting the adoption of instruments utilized for ATP assays, especially in emerging markets.
Opportunity: Technological enhancements in ATP assay probes
Characterizing and understanding ATP dynamics provides valuable mechanistic insights into processes that range from neurotransmission to the chemotaxis of immune cells. Therefore, there is a need for a methodology to interrogate both the temporal and spatial components of ATP dynamics from the subcellular to organismal levels in live specimens. In the last several decades, a number of molecular probes that are specific for ATP have been developed. These probes have been combined with imaging approaches, particularly optical microscopy, to enable the qualitative and quantitative detection of this critical molecule.
While a number of ATP imaging technologies currently exist, there are still gaps in the ability to fully probe ATP metabolism and signaling. 1st generation ATP test methods use basic principles and, as such, provide users with only a semiquantitative measurement of ATP content. Second-generation protocols and reagents are specifically designed to mitigate various types of interferences found in water applications, including suspended solids, dissolved solids, biocides, and organics.
Challenge: Survival of small players and new entrants
The survival of small players and new entrants in the ATP assays market is a significant challenge. Established players have a robust product portfolio and strong brand recognition. As a result, it is difficult for small players and new entrants to compete with established players. Also, it is difficult for small players to sustain their operations and compete with established players that have large R&D budgets.
The consumables and accessories segment accounted for the largest share of the ATP assays, by product in 2021
Based on products, the ATP assays market is segmented into consumables & accessories, and instruments. In 2021, the consumables and accessories segment accounted for the largest share in the market. The large share of this segment is attributed to the extensive usage of ATP assays in research institutes to measure cell viability, increase in drug discovery due to a surge in chronic diseases which requires tumor testing and cell proliferation (in cancer), and the repeated purchase of consumables by pharmaceutical and biotechnology companies.
The contamination testing segment accounted for the largest share of the ATP assays market, by application in 2021
Based on application, the ATP assays market is segmented into contamination testing, disease testing, and drug discovery & development. The large share of the contamination testing segment can be attributed to the rising regulatory stringency of pharmaceutical and food & beverage companies for non-contaminated production, an increase in drug discovery post COVID-19, and the need for cleaning and disinfection of environmental surfaces in hospitals.
The pharmaceutical and biotechnology companies segment accounted for the largest share of the ATP Assays market, by end user in 2021
Based on end users, the ATP assays market is segmented into pharmaceutical & biotechnology companies, the food & beverage industry, hospitals & diagnostic laboratories, and academic & research institutes. The large share of pharmaceutical and biotechnology segment can be attributed to the presence of a large number of pharmaceutical players with growing investments in this market, growing regulatory approvals for cell culture-based vaccines which require the use of ATP assays in contamination testing, commercial expansion of various pharmaceutical companies, the increasing demand for cell and gene therapies for chronic diseases, significant R&D in pharmaceutical & biopharmaceutical companies, increasing production of COVID-19 drugs, increasing adoption of cell-based assays for drug development, and the ease of use of ATP assays in contamination testing.
North America accounted for the largest share of the ATP Assays market in 2021
In 2021, North America accounted for the largest share the ATP assays market, followed by Europe, Asia Pacific, Latin America, and the Middle East & Africa. The large share of North America can be attributed to the large pharmaceutical & biotechnology industry in the region, rising demand for cell-based assays in research, growing food safety concerns, and an increase in government funding for life science research.
North America: ATP Assays Market Snapshot
To know about the assumptions considered for the study, download the pdf brochure
Key Market Players
Major players in the ATP assays market are Thermo Fisher Scientific, Inc. (US), Promega Corporation (US), Merck KGaA (Germany), PerkinElmer, Inc. (US), Agilent Technologies, Inc. (US), Abcam plc (UK), Lonza Group (Switzerland), NEOGEN Corporation (US), 3M (US), Danaher Corporation (US), PromoCell GmbH (Germany), Geno Technology, Inc. (US), Abnova Corporation (Taiwan), AAT Bioquest (US), BioThema AB (Sweden), Elabscience Biotechnology Inc. (US), MBL International Corporation (US), Biotium (US), Creative Bioarray (US), Canvax Biotech S.L. (Spain), Ruhof Corporation (US), Charm Sciences, Inc. (US), Bio Shield Tech LLC (US), Cayman Chemical (US), and Cell Signaling Technology (US).
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
Request Sample Scope of the Report
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
|
Report Metric |
Details |
|
Market size available for years |
2020–2027 |
|
Base year considered |
2021 |
|
Forecast period |
2022–2027 |
|
Forecast units |
Value (USD) |
|
Segments covered |
Product, Application, and End User |
|
Geographies covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa |
|
Companies covered |
Thermo Fisher Scientific, Inc. (US), Promega Corporation (US), Merck KGaA (Germany), PerkinElmer, Inc. (US), Agilent Technologies, Inc. (US), Abcam plc (UK), Lonza Group (Switzerland), NEOGEN Corporation (US), 3M (US), Danaher Corporation (US), PromoCell GmbH (Germany), Geno Technology, Inc. (US), Abnova Corporation (Taiwan), AAT Bioquest (US), BioThema AB (Sweden), Elabscience Biotechnology Inc. (US), MBL International Corporation (US), Biotium (US), Creative Bioarray (US), Canvax Biotech S.L. (Spain), Ruhof Corporation (US), Charm Sciences, Inc. (US), Bio Shield Tech, LLC (US), Cayman Chemical (US), and Cell Signaling Technology (US). |
The study categories the ATP Assays Market based on product, application, end user, and regional and global level.
Global ATP Assays Market, by Product
- Consumables & Accessories
- Reagent
- Microplates
- Other Consumables & Accessories
- Instruments
- Luminometers
- Spectrophotometers
Global ATP Assays Market, by Application
- Contamination Testing
- Disease Testing
- Drug Discovery and Development
Global ATP Assays Market, by End-User
- Pharmaceutical & Biotechnology companies
- Food and Beverage Industry
- Hospitals and Diagnostic Laboratories
- Academic and Research Institutions
Global ATP Assays Market, by Region
- North America
- US
- Canada
- Europe
- France
- Spain
- UK
- Italy
- Germany
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of APAC
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
Recent Developments
- In 2021, Abcam has doubled the footprint of its immunoassay kit R&D and manufacturing facility in Eugene, Oregon. This enhanced capacity is another component of Abcam’s growth journey in the US and will further enable its commitment to support the research and biopharma sector globally.
- In 2020, Merck broadened its manufacturing footprint with a combined investment of USD 44.2 million (EUR 40 million) at its production facilities in Danvers, Massachusetts, and Jaffrey, New Hampshire. These sites supply critical products to customers developing lifesaving therapies, including COVID-19 vaccines, as well as provide products and services for biopharmaceutical manufacturing.
- In 2019, Merck opened its M Lab Collaboration Center in France, which provides biopharmaceutical manufacturers an environment where they can collaborate with Merck’s personnel and have access to Merck’s Life Science product portfolio. This helped in product branding and in expanding Merck’s presence in Europe.
Frequently Asked Questions (FAQ):
Which are the top industry players in the global ATP assays market?
The top market players in the global ATP assays market include Major players in the ATP assays market are Thermo Fisher Scientific, Inc. (US), Promega Corporation (US), Merck KGaA (Germany), PerkinElmer, Inc. (US), Agilent Technologies, Inc. (US) and Neogen Corporation (US).
Which global ATP assays products have been included in this report?
This report contains the following main segments:
- Consumables and Accessories
- Instruments
Which geographical region is dominating in the global ATP assays market?
The global ATP assays market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America accounted for the largest share of the market, followed by Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America has the largest pharmaceutical & biotechnology industry globally, with major investments in the R&D of various pharma & biotech products. North America also leads in the number of approved drugs. Considering these factors, the demand and uptake of ATP assays are high in major end-user segments in North America, and this trend is expected to continue during the forecast period. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 24)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION & SCOPE
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.2.2 MARKET SEGMENTATION
FIGURE 1 ATP ASSAYS MARKET SEGMENTATION
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 29)
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND-SIDE PARTICIPANTS
2.2 MARKET SIZE ESTIMATION
FIGURE 7 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION
FIGURE 9 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 10 CAGR PROJECTIONS
FIGURE 11 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 12 DATA TRIANGULATION METHODOLOGY
2.4 MARKET RANKING ANALYSIS
2.5 ASSUMPTIONS FOR THE STUDY
2.6 LIMITATIONS
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.6.2 SCOPE-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: ATP ASSAYS MARKET
3 EXECUTIVE SUMMARY (Page No. - 42)
FIGURE 13 ATP ASSAYS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 14 ATP ASSAYS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 15 ATP ASSAYS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 16 GEOGRAPHICAL SNAPSHOT OF THE ATP ASSAYS MARKET
4 PREMIUM INSIGHTS (Page No. - 46)
4.1 ATP ASSAYS MARKET OVERVIEW
FIGURE 17 INCREASING FOOD SAFETY CONCERNS TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: ATP ASSAYS MARKET, BY END USER AND COUNTRY (2021)
FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE APAC MARKET IN 2021
4.3 ATP ASSAYS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 19 CHINA TO REGISTER THE HIGHEST GROWTH IN THE ATP ASSAYS MARKET DURING THE FORECAST PERIOD
4.4 ATP ASSAYS MARKET, BY REGION (2020–2027)
FIGURE 20 NORTH AMERICA WILL CONTINUE TO DOMINATE THE ATP ASSAYS MARKET IN 2027
4.5 ATP ASSAYS MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 21 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 50)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
TABLE 3 ATP ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 MARKET DRIVERS
5.2.1.1 Increasing food safety concerns
5.2.1.2 Growing demand for ATP assays in pharmaceutical & biotechnology companies
5.2.1.3 Rising investments in pharmaceutical & biotechnology R&D
FIGURE 22 GLOBAL PHARMACEUTICAL R&D SPENDING, 2012–2026 (USD BILLION)
5.2.1.4 Increasing prevalence of cancer
FIGURE 23 GLOBAL CANCER INCIDENCE, 2018 VS. 2030 (MILLION)
5.2.1.5 Shift from culture-based tests to rapid-tests
5.2.1.6 Rising incidence and prevalence of chronic and infectious diseases
5.2.2 MARKET RESTRAINTS
5.2.2.1 High cost of instruments
5.2.2.2 Inability to differentiate between extracellular and intracellular ATP
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 Technological enhancements in ATP assay probes
5.2.3.2 Growth prospects in emerging markets
5.2.4 MARKET CHALLENGES
5.2.4.1 Survival of small players and new entrants
5.3 INDUSTRY TRENDS
5.3.1 INCREASING REGULATIONS FOR FOOD BUSINESSES
5.3.2 ADOPTION OF ATP TESTING FOR MONITORING ENVIRONMENTAL CONTAMINATION CAUSED BY SARS-COV-2
5.4 IMPACT OF COVID-19 ON THE ATP ASSAYS MARKET
5.5 PATENT ANALYSIS
5.5.1 PATENT PUBLICATION TRENDS FOR ATP ASSAYS
FIGURE 24 PATENT PUBLICATION TRENDS (JANUARY 2011–FEBRUARY 2022)
5.5.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 25 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTES) FOR ATP ASSAY PATENTS (JANUARY 2011–FEBRUARY 2022)
FIGURE 26 TOP APPLICANT COUNTRIES/REGIONS FOR ATP ASSAYS (JANUARY 2011–FEBRUARY 2022)
5.5.3 LIST OF PATENTS/PATENT APPLICATIONS IN THE ATP ASSAYS MARKET
5.6 VALUE CHAIN ANALYSIS
FIGURE 27 ATP ASSAYS MARKET: VALUE CHAIN ANALYSIS
5.7 ECOSYSTEM ANALYSIS
FIGURE 28 ATP ASSAYS MARKET: ECOSYSTEM ANALYSIS
5.8 PORTER’S FIVE FORCES ANALYSIS
TABLE 4 ATP ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.8.1 THREAT OF NEW ENTRANTS
5.8.2 THREAT OF SUBSTITUTES
5.8.3 BARGAINING POWER OF SUPPLIERS
5.8.4 BARGAINING POWER OF BUYERS
5.8.5 INTENSITY OF COMPETITIVE RIVALRY
5.9 PRICING ANALYSIS
5.9.1 REGIONAL PRICING ANALYSIS OF ATP ASSAYS, 2021 (USD)
6 ATP ASSAYS MARKET, BY PRODUCT (Page No. - 70)
6.1 INTRODUCTION
TABLE 5 ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
6.2 CONSUMABLES & ACCESSORIES
TABLE 6 KEY ATP CONSUMABLES & ACCESSORIES AVAILABLE IN THE MARKET
TABLE 7 ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 8 ATP CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1 REAGENTS & KITS
6.2.1.1 Reagents play a significant role in the identification and detection of cells in cancer research
TABLE 9 REAGENTS & KITS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.2 MICROPLATES
6.2.2.1 Extensive use of microplates for assay development is driving their adoption
TABLE 10 MICROPLATES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.3 OTHER CONSUMABLES & ACCESSORIES
TABLE 11 OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3 INSTRUMENTS
TABLE 12 ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 13 ATP INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 14 KEY ATP INSTRUMENTS AVAILABLE IN THE MARKET
6.3.1 LUMINOMETERS
6.3.1.1 Luminometers are comparatively low-priced and, therefore, widely adopted
TABLE 15 LUMINOMETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.2 SPECTROPHOTOMETERS
6.3.2.1 Spectrophotometers are costlier than luminometers and, therefore, less preferred by end users in the ATP assays market
TABLE 16 SPECTROPHOTOMETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7 ATP ASSAYS MARKET, BY APPLICATION (Page No. - 81)
7.1 INTRODUCTION
TABLE 17 ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
7.2 CONTAMINATION TESTING
7.2.1 NEED TO MEET REGULATORY MANDATES FOR CONTAMINATION AND QUALITY TESTING IS A KEY FACTOR DRIVING MARKET GROWTH
TABLE 18 ATP ASSAYS MARKET FOR CONTAMINATION TESTING, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 DISEASE TESTING
7.3.1 GROWING DISEASE INCIDENCE AND RISING AWARENESS ARE EXPECTED TO SUPPORT MARKET GROWTH DURING THE FORECAST PERIOD
TABLE 19 ATP ASSAYS MARKET FOR DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION)
7.4 DRUG DISCOVERY & DEVELOPMENT
7.4.1 INCREASING R&D PIPELINE FOR PHARMACEUTICAL DRUGS WILL DRIVE MARKET GROWTH
TABLE 20 ATP ASSAYS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)
8 ATP ASSAYS MARKET, BY END USER (Page No. - 87)
8.1 INTRODUCTION
TABLE 21 ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ARE THE LARGEST & FASTEST-GROWING END USERS OF ATP ASSAYS
TABLE 22 ATP ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 FOOD & BEVERAGE INDUSTRY
8.3.1 RISING INCIDENCE OF FOOD CONTAMINATION TO DRIVE THE ADOPTION OF ATP ASSAYS
TABLE 23 ATP ASSAYS MARKET FOR FOOD & BEVERAGE INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION)
8.4 HOSPITALS & DIAGNOSTIC LABORATORIES
8.4.1 GROWING DEMAND FOR EARLY DISEASE DIAGNOSIS IS A MAJOR FACTOR DRIVING THE ADOPTION OF ATP ASSAYS
TABLE 24 ATP ASSAYS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)
8.5 ACADEMIC & RESEARCH INSTITUTES
8.5.1 ATP ASSAYS ARE USED FOR RESEARCH ACTIVITIES RELATED TO THE GROWTH RATE & VIABILITY OF MICROORGANISMS
TABLE 25 ATP ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
9 ATP ASSAYS MARKET, BY REGION (Page No. - 94)
9.1 INTRODUCTION
TABLE 26 ATP ASSAYS MARKET, BY REGION, 2020–2027 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 30 NORTH AMERICA: ATP ASSAYS MARKET SNAPSHOT
TABLE 27 NORTH AMERICA: ATP ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 28 NORTH AMERICA: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 29 NORTH AMERICA: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 30 NORTH AMERICA: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 31 NORTH AMERICA: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 32 NORTH AMERICA: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.1 US
9.2.1.1 US dominates the North American ATP assays market
TABLE 33 US: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 34 US: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 35 US: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 36 US: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 37 US: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Government funding programs for life science research to drive market growth
TABLE 38 CANADA: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 39 CANADA: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 40 CANADA: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 41 CANADA: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 42 CANADA: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3 EUROPE
FIGURE 31 EUROPE: PHARMACEUTICAL R&D EXPENDITURE, 2000–2018 (USD BILLION)
TABLE 43 EUROPE: ATP ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 44 EUROPE: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 45 EUROPE: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 46 EUROPE: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 47 EUROPE: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 48 EUROPE: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Demand for ATP assays is driven by the large-scale outsourcing of clinical diagnostic testing by hospitals to commercial service providers
TABLE 49 GERMANY: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 50 GERMANY: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 51 GERMANY: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 52 GERMANY: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 53 GERMANY: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.2 UK
9.3.2.1 UK has the largest pharmaceutical R&D expenditure in Europe
TABLE 54 UK: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 55 UK: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 56 UK: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 57 UK: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 58 UK: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Strong agro-food sector and a major focus on biotechnology R&D to drive market growth in France
TABLE 59 FRANCE: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 60 FRANCE: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 61 FRANCE: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 62 FRANCE: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 63 FRANCE: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.4 ITALY
9.3.4.1 High cancer burden to increase the demand for ATP assays in Italy
TABLE 64 ITALY: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 65 ITALY: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 66 ITALY: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 67 ITALY: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 68 ITALY: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Growth in the personalized medicine sector and clinical diagnostics market to drive the ATP assays market in Spain
TABLE 69 SPAIN: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 70 SPAIN: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 71 SPAIN: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 72 SPAIN: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 73 SPAIN: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 74 ROE: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 75 ROE: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 76 ROE: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 77 ROE: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 78 ROE: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 32 ASIA PACIFIC: ATP ASSAYS MARKET SNAPSHOT
TABLE 79 ASIA PACIFIC: ATP ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 80 ASIA PACIFIC: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 81 ASIA PACIFIC: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 82 ASIA PACIFIC: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 83 ASIA PACIFIC: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 84 ASIA PACIFIC: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.1 CHINA
9.4.1.1 Increasing pharmaceutical R&D investments in the country to support market growth
TABLE 85 CHINA: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 86 CHINA: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 87 CHINA: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 88 CHINA: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 89 CHINA: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 High incidence of cancer to increase the demand for ATP assays in Japan
TABLE 90 JAPAN: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 91 JAPAN: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 92 JAPAN: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 93 JAPAN: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 94 JAPAN: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Growing adoption of ATP assay techniques in research and clinical applications to drive the market in India
TABLE 95 INDIA: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 96 INDIA: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 97 INDIA: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 98 INDIA: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 99 INDIA: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.4 REST OF APAC
TABLE 100 ROAPAC: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 101 ROAPAC: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 102 ROAPAC: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 103 ROAPAC: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 104 ROAPAC: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5 LATIN AMERICA
TABLE 105 LATIN AMERICA: ATP ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 106 LATIN AMERICA: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 107 LATIN AMERICA: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 108 LATIN AMERICA: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 109 LATIN AMERICA: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 110 LATIN AMERICA: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 Increasing research activities & expanding pharmaceutical market in Brazil is fueling the market for ATP assays
TABLE 111 BRAZIL: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 112 BRAZIL: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 113 BRAZIL: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 114 BRAZIL: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 115 BRAZIL: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5.2 MEXICO
9.5.2.1 Increase in research centers and manufacturing to drive the demand for ATP assays in Mexico
TABLE 116 MEXICO: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 117 MEXICO: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 118 MEXICO: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 119 MEXICO: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 120 MEXICO: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5.3 REST OF LATIN AMERICA
TABLE 121 ROLATAM: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 122 ROLATAM: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 123 ROLATAM: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 124 ROLATAM: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 125 ROLATAM: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 GROWING FUNDING INITIATIVES AND STRATEGIC PARTNERSHIPS IS DRIVING MARKET GROWTH IN THE MEA
TABLE 126 MEA: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 127 MEA: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 128 MEA: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 129 MEA: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 130 MEA: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 148)
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE ATP ASSAYS MARKET
10.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
FIGURE 33 REVENUE ANALYSIS OF THE TOP PLAYERS IN THE ATP ASSAYS MARKET
10.4 MARKET RANKING ANALYSIS
FIGURE 34 ATP ASSAYS MARKET RANKING, BY KEY PLAYER, 2021
10.5 COMPETITIVE LEADERSHIP MAPPING
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 35 ATP ASSAYS MARKET: COMPETITIVE LEADERSHIP MAPPING (2021)
10.6 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS
10.6.1 PROGRESSIVE COMPANIES
10.6.2 DYNAMIC COMPANIES
10.6.3 STARTING BLOCKS
10.6.4 RESPONSIVE COMPANIES
FIGURE 36 ATP ASSAYS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS (2021)
10.7 COMPANY FOOTPRINT
TABLE 131 COMPANY FOOTPRINT: ATP ASSAYS MARKET (2021)
10.7.1 PRODUCT FOOTPRINT OF MAJOR PLAYERS IN THE ATP ASSAYS MARKET
TABLE 132 PRODUCT FOOTPRINT: ATP ASSAYS MARKET (2021)
10.7.2 APPLICATION FOOTPRINT OF MAJOR PLAYERS IN THE ATP ASSAYS MARKET
TABLE 133 APPLICATION FOOTPRINT: ATP ASSAYS MARKET (2021)
10.7.3 END-USER FOOTPRINT OF MAJOR PLAYERS IN THE ATP ASSAYS MARKET
TABLE 134 END-USER FOOTPRINT: ATP ASSAYS MARKET (2021)
10.7.4 GEOGRAPHIC FOOTPRINT OF MAJOR PLAYERS IN THE ATP ASSAYS MARKET
TABLE 135 GEOGRAPHIC FOOTPRINT: ATP ASSAYS MARKET (2021)
10.8 COMPETITIVE SCENARIO
10.8.1 PRODUCT LAUNCHES
TABLE 136 PRODUCT LAUNCHES, JANUARY 2018–FEBRUARY 2022
10.8.2 DEALS
TABLE 137 DEALS, JANUARY 2018–FEBRUARY 2022
10.8.3 OTHER DEVELOPMENTS
11 COMPANY PROFILES (Page No. - 165)
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 THERMO FISHER SCIENTIFIC, INC.
TABLE 139 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
FIGURE 37 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021)
11.1.2 PROMEGA CORPORATION
TABLE 140 PROMEGA CORPORATION: BUSINESS OVERVIEW
11.1.3 MERCK KGAA
FIGURE 38 MERCK KGAA: COMPANY SNAPSHOT (2021)
11.1.4 NEOGEN CORPORATION
TABLE 142 NEOGEN CORPORATION: BUSINESS OVERVIEW
FIGURE 39 NEOGEN CORPORATION: COMPANY SNAPSHOT (2021)
11.1.5 PERKINELMER, INC.
FIGURE 40 PERKINELMER, INC.: COMPANY SNAPSHOT (2021)
11.1.6 AGILENT TECHNOLOGIES, INC.
FIGURE 41 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2021)
11.1.7 PROMOCELL GMBH
11.1.8 DANAHER CORPORATION
FIGURE 42 DANAHER CORPORATION: COMPANY SNAPSHOT (2021)
11.1.9 LONZA GROUP
TABLE 147 LONZA GROUP: BUSINESS OVERVIEW
FIGURE 43 LONZA GROUP: COMPANY SNAPSHOT (2021)
11.1.10 ABCAM PLC
FIGURE 44 ABCAM PLC: COMPANY SNAPSHOT (2021)
11.1.11 3M
FIGURE 45 3M: COMPANY SNAPSHOT (2021)
11.1.12 ABNOVA CORPORATION
FIGURE 46 ABNOVA CORPORATION: COMPANY SNAPSHOT (2020)
11.1.13 GENO TECHNOLOGY, INC.
TABLE 151 GENO TECHNOLOGY, INC.: BUSINESS OVERVIEW
11.1.14 AAT BIOQUEST, INC.
TABLE 152 AAT BIOQUEST, INC.: BUSINESS OVERVIEW
11.1.15 BIOTHEMA AB
11.1.16 BIOTIUM
11.1.17 CREATIVE BIOARRAY
11.1.18 CANVAX BIOTECH S.L.
11.1.19 ELABSCIENCE BIOTECHNOLOGY INC.
11.1.20 MBL INTERNATIONAL CORPORATION
TABLE 158 MBL INTERNATIONAL CORPORATION: BUSINESS OVERVIEW
11.2 OTHER COMPANIES
11.2.1 RUHOF CORPORATION
11.2.2 CHARM SCIENCES
11.2.3 BIO SHIELD TECH, LLC
11.2.4 CAYMAN CHEMICAL
11.2.5 CELL SIGNALING TECHNOLOGY
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX (Page No. - 218)
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
Secondary Research
This research study involved the use of comprehensive secondary sources; directories and databases such as D&B, Bloomberg Business, and Factiva; and white papers, annual reports, and companies’ house documents. Secondary research was used to identify and collect information for this extensive, technical, market-oriented, and commercial study of the ATP assays market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, technology perspectives, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side and demand side are detailed below. Industry experts such as CEOs, presidents, vice presidents, directors, marketing directors, marketing managers, and related executives from various key companies and organizations in the ATP assays industry were interviewed to obtain and verify both the qualitative and quantitative aspects of this research study. A robust primary research methodology has been adopted to validate the contents of the report and fill in the gaps.
A breakdown of the primary respondents is provided below:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis) primary interviews, and top-down approach (assessment of Individual shares of each ATP assay product, application, and end-user segment).
Data Triangulation
After arriving at the market size, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, data triangulation, and market breakdown procedures were employed, wherever applicable.
Objectives of the Study
- To define, describe, segment, and forecast the ATP assays market by product, application, end user, and region
- To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall ATP assays market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To estimate and forecast the size of the ATP assays market in five main regions (along with their respective key countries), namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players in the ATP assays market and comprehensively analyze their core competencies2 and market shares
- To track and analyze competitive developments, such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships, of the leading players in the ATP assays market
- To benchmark players within the ATP assays market using the competitive leadership mapping framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering
- To evaluate and analyze the impact of COVID-19 on the ATP assays market
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
- Further breakdown of the Rest of Europe ATP assays market into Switzerland, the Netherlands, Belgium, and others.
- Further breakdown of the Middle East & Africa ATP assays market into Saudi Arabia, the UAE, and others.
Company Information
- Detailed analysis and profiling of additional market players (up to five)
Growth opportunities and latent adjacency in ATP Assays Market